Literature DB >> 3396222

Role of the plasma contact system in the pathogenesis of experimental anti-GBM glomerulonephritis.

J Villaro1, A Sánchez Ibarrola, A Purroy.   

Abstract

To study the participation of the Hageman factor-related contact system of plasma in the pathogenesis of glomerulonephritis (GN), an anti-BM GN was induced in a group of 10 normal Brown Norway rats and another of seven Brown Norway BN/Mai Pfd f rats. The latter strain is characterized by a congenital deficiency of plasma prekallikrein and of high-molecular weight kininogen, with lengthening of the activated partial thromboplastin time. In the deficient group, one animal developed crescents in less than 25% of glomeruli, five in 25-50% and one in 50-75%. In the group of normal rats, extracapillary proliferation was of greater severity: one animal showed crescents in less than 25% of glomeruli, two in 50-75% and five in more than 75% of glomeruli. Although in both groups intense glomerular fibrin deposition was documented, the intensity of these deposits was less severe in the deficient animals. These data suggest, in the first place, that functional integrity of the contact system is not a necessary requirement for glomerular fibrinogenesis, other mechanisms being implicated in this phenomenon. On the other hand, this functional deficit has exerted a protective effect on crescent formation, which suggests that the contact system can play a role as a mediator of injury in glomerulonephritis, perhaps through the release of contact system-dependent mediators of inflammation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396222      PMCID: PMC1541497     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Heparin therapy in anti-basement membrane nephritis.

Authors:  J M Bone; A J Valdes; F G Germuth; H Lubowitz
Journal:  Kidney Int       Date:  1975-08       Impact factor: 10.612

2.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

3.  Chromogenic substrate assay of plasma prekallikrein. With a note on its site of biosynthesis.

Authors:  H Stormorken; A Baklund; M Gallimore; S Ritland
Journal:  Haemostasis       Date:  1978

Review 4.  The biochemistry and pathophysiology of the contact system of plasma.

Authors:  C G Cochrane; J H Griffin
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

5.  Hageman factor deposition in membranous glomerulopathy.

Authors:  J Berger; H Yaneva
Journal:  Transplant Proc       Date:  1982-09       Impact factor: 1.066

6.  Congenital deficiency in plasma kallikrein and kininogens in the brown Norway rat.

Authors:  J Damas; A Adam
Journal:  Experientia       Date:  1980-05-15

7.  Participation of kallikrein, coagulation/fibrinolysis parameters in the development of glomerulonephritis.

Authors:  K Nakamura; M Kazama; T Abe
Journal:  Adv Exp Med Biol       Date:  1979       Impact factor: 2.622

8.  Studies on the adsorption and activation of the Hageman factor (factor XII) by collagen and elastin.

Authors:  S Niewiarowski; E Bańkowski; I Rogowicka
Journal:  Thromb Diath Haemorrh       Date:  1965-11-15

9.  Failure of heparin to affect two types of experimental glomerulonephritis in rabbits.

Authors:  W A Border; C B Wilson; F J Dixon
Journal:  Kidney Int       Date:  1975-09       Impact factor: 10.612

Review 10.  Mediating systems in inflammatory disease.

Authors:  C G Cochrane
Journal:  J Invest Dermatol       Date:  1978-07       Impact factor: 8.551

View more
  2 in total

Review 1.  Tissue factor in crescentic glomerulonephritis.

Authors:  R T McCluskey
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

2.  Effect of fibrin matrix on growth of glomerular cells.

Authors:  A H Yang; H J Chang
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.